$NURO
NeuroMetrix, Inc. Stock $nuro

$nuro Overview Financials Valuation SEC Filings Company Website

2023 Q2 Form 10-Q Financial Statement

#000162828023015243 Filed on May 03, 2023

Income Statement

Concept	2023 Q2	2023 Q1
Revenue	$1.656M	$1.725M
YoY Change	-22.57%	-25.09%
Cost Of Revenue	$536.5K	$526.4K
YoY Change	-21.81%	3.44%
Gross Profit	$1.119M	$1.198M
YoY Change	-22.93%	-33.18%
Gross Profit Margin	67.6%	69.48%
Selling, General & Admin	$1.989M	$2.209M
YoY Change	13.88%	8.03%
% of Gross Profit	177.73%	184.33%
Research & Development	$753.5K	$699.4K
YoY Change	-17.72%	-1.57%
% of Gross Profit	67.32%	58.36%
Depreciation & Amortization	$10.22K	$10.22K
YoY Change	-23.73%	-20.62%
% of Gross Profit	0.91%	0.85%
Operating Expenses	$2.743M	$2.908M
YoY Change	3.01%	5.55%
Operating Profit	-$1.623M	-$1.710M
YoY Change	34.13%	77.76%
Interest Expense
YoY Change
% of Operating Profit
Other Income/Expense, Net	$86.43K	$135.9K
YoY Change	71.49%	3862.1%
Pretax Income	-$1.537M	-$1.574M
YoY Change	32.51%	64.22%
Income Tax
% Of Pretax Income
Net Earnings	-$1.537M	-$1.574M
YoY Change	32.51%	64.22%
Net Earnings / Revenue	-92.83%	-91.27%
Basic Earnings Per Share	-$0.19	-$0.20
Diluted Earnings Per Share	-$0.19	-$0.20
COMMON SHARES
Basic Shares Outstanding	7.840M shares	7.792M shares
Diluted Shares Outstanding	7.886M shares	7.689M shares

Balance Sheet

Concept	2023 Q2	2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments	$19.63M	$20.25M
YoY Change	-14.55%	-14.79%
Cash & Equivalents	$1.863M	$2.377M
Short-Term Investments	$17.76M	$17.88M
Other Short-Term Assets	$331.5K	$508.4K
YoY Change	37.18%	20.29%
Inventory	$1.584M	$1.748M
Prepaid Expenses
Receivables	$746.7K	$576.3K
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$22.29M	$23.09M
YoY Change	-9.49%	-9.77%
LONG-TERM ASSETS
Property, Plant & Equipment	$457.7K	$155.4K
YoY Change	155.72%	-15.7%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$26.40K	$26.40K
YoY Change	0.0%	0.0%
Total Long-Term Assets	$484.1K	$523.9K
YoY Change	-23.17%	-20.76%
TOTAL ASSETS
Total Short-Term Assets	$22.29M	$23.09M
Total Long-Term Assets	$484.1K	$523.9K
Total Assets	$22.77M	$23.61M
YoY Change	-9.83%	-10.05%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$181.5K	$400.3K
YoY Change	-54.7%	10.93%
Accrued Expenses	$1.028M	$868.3K
YoY Change	-0.21%	-28.06%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$1.210M	$1.417M
YoY Change	-23.79%	-17.96%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$152.1K	$180.4K
YoY Change	-41.24%	-36.32%
Total Long-Term Liabilities	$152.1K	$180.4K
YoY Change	-41.24%	-36.32%
TOTAL LIABILITIES
Total Short-Term Liabilities	$1.210M	$1.417M
Total Long-Term Liabilities	$152.1K	$180.4K
Total Liabilities	$1.362M	$1.597M
YoY Change	-26.23%	-20.55%
SHAREHOLDERS EQUITY
Retained Earnings	-$206.7M	-$205.2M
YoY Change	2.69%	2.51%
Common Stock	$858.00	$778.00
YoY Change	20.34%	10.98%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$21.41M	$22.01M
YoY Change
Total Liabilities & Shareholders Equity	$22.77M	$23.61M
YoY Change	-9.83%	-10.05%

Cashflow Statement

Concept	2023 Q2	2023 Q1
OPERATING ACTIVITIES
Net Income	-$1.537M	-$1.574M
YoY Change	32.51%	64.22%
Depreciation, Depletion And Amortization	$10.22K	$10.22K
YoY Change	-23.73%	-20.62%
Cash From Operating Activities	-$1.451M	-$1.121M
YoY Change	73.1%	51.46%
INVESTING ACTIVITIES
Capital Expenditures	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Acquisitions
YoY Change
Other Investing Activities	$237.3K	-$837.0K
YoY Change	-101.4%
Cash From Investing Activities	$237.3K	-$837.0K
YoY Change	-101.4%	15414.07%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	700.1K	$0.00
YoY Change	8841.51%	-100.0%
NET CHANGE
Cash From Operating Activities	-1.451M	-$1.121M
Cash From Investing Activities	237.3K	-$837.0K
Cash From Financing Activities	700.1K	$0.00
Net Change In Cash	-513.7K	-$1.958M
YoY Change	-97.11%	-263.57%
FREE CASH FLOW
Cash From Operating Activities	-$1.451M	-$1.121M
Capital Expenditures	$0.00	$0.00
Free Cash Flow	-$1.451M	-$1.121M
YoY Change	74.77%	50.37%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q1	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023Q1	dei	Entity Central Index Key EntityCentralIndexKey	0001289850
CY2023Q1	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022Q1	us-gaap	Other Comprehensive Income Loss Net Of Tax OtherComprehensiveIncomeLossNetOfTax	0	usd
CY2023Q1	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2023Q1	dei	Amendment Flag AmendmentFlag	false
CY2023Q1	dei	Document Type DocumentType	10-Q
CY2023Q1	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2023Q1	dei	Document Period End Date DocumentPeriodEndDate	2023-03-31
CY2023Q1	dei	Document Transition Report DocumentTransitionReport	false
CY2023Q1	dei	Entity File Number EntityFileNumber	001-33351
CY2023Q1	dei	Entity Registrant Name EntityRegistrantName	NEUROMETRIX, INC.
CY2023Q1	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2023Q1	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	04-3308180
CY2023Q1	dei	Entity Address Address Line1 EntityAddressAddressLine1	4B Gill Street
CY2023Q1	dei	Entity Address City Or Town EntityAddressCityOrTown	Woburn
CY2023Q1	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
CY2023Q1	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	01801
CY2023Q1	dei	City Area Code CityAreaCode	781
CY2023Q1	dei	Local Phone Number LocalPhoneNumber	890-9989
CY2023Q1	dei	Security12b Title Security12bTitle	Common Stock, $0.0001 par value per share
CY2023Q1	dei	Trading Symbol TradingSymbol	NURO
CY2023Q1	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q1	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023Q1	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023Q1	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2023Q1	dei	Entity Small Business EntitySmallBusiness	true
CY2023Q1	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023Q1	dei	Entity Shell Company EntityShellCompany	false
CY2023Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	7839549	shares
CY2023Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	2376619	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	4335020	usd
CY2023Q1	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	8473905	usd
CY2022Q4	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	16864707	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	9402858	usd
CY2022Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	0	usd
CY2023Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	576281	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	646771	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	1748115	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	1614987	usd
CY2023Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	508391	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	645502	usd
CY2023Q1	us-gaap	Assets Current AssetsCurrent	23086169	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	24106987	usd
CY2023Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	155397	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	165619	usd
CY2023Q1	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	342082	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	370609	usd
CY2023Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	26400	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	26400	usd
CY2023Q1	us-gaap	Assets Assets	23610048	usd
CY2022Q4	us-gaap	Assets Assets	24669615	usd
CY2023Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	400299	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	368082	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	868265	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	589939	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	148391	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	148391	usd
CY2023Q1	us-gaap	Liabilities Current LiabilitiesCurrent	1416955	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	1106412	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	180345	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	207516	usd
CY2023Q1	us-gaap	Liabilities Liabilities	1597300	usd
CY2022Q4	us-gaap	Liabilities Liabilities	1313928	usd
CY2023Q1	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023Q1	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2023Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000	shares
CY2023Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7781156	shares
CY2023Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7781156	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	7771938	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	7771938	shares
CY2023Q1	us-gaap	Common Stock Value CommonStockValue	778	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	777	usd
CY2023Q1	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	227100135	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	226934775	usd
CY2023Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	65874	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	0	usd
CY2023Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-205154040	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-203579866	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	22012748	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	23355687	usd
CY2023Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	23610048	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	24669615	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1724771	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2302391	usd
CY2023Q1	us-gaap	Cost Of Revenue CostOfRevenue	526372	usd
CY2022Q1	us-gaap	Cost Of Revenue CostOfRevenue	508874	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	1198399	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	1793517	usd
CY2023Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	699425	usd
CY2022Q1	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	710577	usd
CY2023Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	815872	usd
CY2022Q1	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	858839	usd
CY2023Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1393171	usd
CY2022Q1	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1186091	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	2908468	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	2755507	usd
CY2023Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-1710069	usd
CY2022Q1	us-gaap	Operating Income Loss OperatingIncomeLoss	-961990	usd
CY2023Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	135895	usd
CY2022Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	3428	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1574174	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-958562	usd
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.20
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.20
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1574174	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-958562	usd
CY2023Q1	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	65874	usd
CY2022Q1	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	0	usd
CY2023Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-1508300	usd
CY2022Q1	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-958562	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	23355687	usd
CY2023Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	165361	usd
CY2023Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	usd
CY2023Q1	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	65874	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1574174	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	22012748	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	23215786	usd
CY2022Q1	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	37632	usd
CY2022Q1	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	1943052	usd
CY2022Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	0	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-958562	usd
CY2022Q1	us-gaap	Stockholders Equity StockholdersEquity	24237908	usd
CY2023Q1	us-gaap	Profit Loss ProfitLoss	-1574174	usd
CY2022Q1	us-gaap	Profit Loss ProfitLoss	-958562	usd
CY2023Q1	us-gaap	Depreciation Depreciation	10222	usd
CY2022Q1	us-gaap	Depreciation Depreciation	12877	usd
CY2023Q1	us-gaap	Share Based Compensation ShareBasedCompensation	165361	usd
CY2022Q1	us-gaap	Share Based Compensation ShareBasedCompensation	37632	usd
CY2023Q1	us-gaap	Inventory Write Down InventoryWriteDown	63420	usd
CY2022Q1	us-gaap	Inventory Write Down InventoryWriteDown	0	usd
CY2023Q1	us-gaap	Investment Income Net Amortization Of Discount And Premium InvestmentIncomeNetAmortizationOfDiscountAndPremium	109198	usd
CY2022Q1	us-gaap	Investment Income Net Amortization Of Discount And Premium InvestmentIncomeNetAmortizationOfDiscountAndPremium	0	usd
CY2023Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	0	usd
CY2022Q1	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-6875	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-70490	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	372501	usd
CY2023Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	196548	usd
CY2022Q1	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	5383	usd
CY2023Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-78467	usd
CY2022Q1	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-37009	usd
CY2023Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	32217	usd
CY2022Q1	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	76819	usd
CY2023Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	338326	usd
CY2022Q1	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	424853	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-1121417	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-740381	usd
CY2023Q1	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	9336984	usd
CY2022Q1	us-gaap	Payments To Acquire Held To Maturity Securities PaymentsToAcquireHeldToMaturitySecurities	0	usd
CY2023Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities	8500000	usd
CY2022Q1	us-gaap	Proceeds From Maturities Prepayments And Calls Of Held To Maturity Securities ProceedsFromMaturitiesPrepaymentsAndCallsOfHeldToMaturitySecurities	0	usd
CY2023Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	0	usd
CY2022Q1	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	5395	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-836984	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5395	usd
CY2023Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	0	usd
CY2022Q1	us-gaap	Proceeds From Issuance Or Sale Of Equity ProceedsFromIssuanceOrSaleOfEquity	1943052	usd
CY2023Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	0	usd
CY2022Q1	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	1943052	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1958401	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	1197276	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	4335020	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	22572104	usd
CY2023Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	2376619	usd
CY2022Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	23769380	usd
CY2023Q1	us-gaap	Cash Cash Equivalents And Short Term Investments CashCashEquivalentsAndShortTermInvestments	20300000	usd
CY2023Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	25000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	25000	usd
CY2023Q1	us-gaap	Use Of Estimates UseOfEstimates	<div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Use of Estimates</span></div><div style="text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> </span></div><div style="text-indent:18pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make significant estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during reporting periods. Actual results could differ from those estimates.</span></div>
CY2023Q1	us-gaap	Other Comprehensive Income Availableforsale Securities Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent	65874	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1574174	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1574174	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-958562	usd
CY2023Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	7689226	shares
CY2022Q1	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6879348	shares
CY2023Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	7689226	shares
CY2022Q1	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6879348	shares
CY2023Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.20
CY2023Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.20
CY2022Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.14
CY2022Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.14
CY2023Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	791298	shares
CY2022Q1	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	557818	shares
CY2023Q1	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	8473905	usd
CY2023Q1	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	8337619	usd
CY2022Q4	us-gaap	Held To Maturity Securities HeldToMaturitySecurities	16864707	usd
CY2022Q4	us-gaap	Held To Maturity Securities Fair Value HeldToMaturitySecuritiesFairValue	16794874	usd
CY2023Q1	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	9336985	usd
CY2023Q1	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	65874	usd
CY2023Q1	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	9402858	usd
CY2022Q4	us-gaap	Inventory Net InventoryNet	1614987	usd
CY2023Q1	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	11070555	usd
CY2022Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	1551027	usd
CY2023Q1	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	1119662	usd
CY2022Q4	us-gaap	Inventory Raw Materials Net Of Reserves InventoryRawMaterialsNetOfReserves	982129	usd
CY2023Q1	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	628453	usd
CY2022Q4	us-gaap	Inventory Finished Goods Net Of Reserves InventoryFinishedGoodsNetOfReserves	632858	usd
CY2023Q1	us-gaap	Inventory Net InventoryNet	1748115	usd
CY2023Q1	us-gaap	Inventory Write Down InventoryWriteDown	63420	usd
CY2023Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	212000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	155000	usd
CY2023Q1	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	361115	usd
CY2022Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	249224	usd
CY2023Q1	nuro	Accrued Clinical Current AccruedClinicalCurrent	40000	usd
CY2022Q4	nuro	Accrued Clinical Current AccruedClinicalCurrent	0	usd
CY2023Q1	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	15100	usd
CY2022Q4	us-gaap	Product Warranty Accrual Classified Current ProductWarrantyAccrualClassifiedCurrent	16700	usd
CY2023Q1	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	132045	usd
CY2022Q4	us-gaap	Sales And Excise Tax Payable Current SalesAndExciseTaxPayableCurrent	131621	usd
CY2023Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	108005	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	37394	usd
CY2023Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	868265	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	589939	usd
CY2022Q1	nuro	Rent Expense Reduction RentExpenseReduction	60000	usd
CY2022Q1	us-gaap	Sublease Income SubleaseIncome	22795	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Remainder Of Fiscal Year LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear	124339	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	165785	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	117431	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	407555	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.15
CY2023Q1	nuro	Operating Lease Discount OperatingLeaseDiscount	78819	usd
CY2023Q1	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	148391	usd
CY2023Q1	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	180345	usd
CY2023Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	407555	usd
CY2023Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	49232	usd
CY2022Q1	us-gaap	Operating Lease Expense OperatingLeaseExpense	24754	usd
CY2023Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y6M
CY2022Q1	us-gaap	Stock Issued During Period Shares Restricted Stock Award Gross StockIssuedDuringPeriodSharesRestrictedStockAwardGross	20000	shares
CY2022Q1	us-gaap	Stock Issued During Period Value Restricted Stock Award Gross StockIssuedDuringPeriodValueRestrictedStockAwardGross	104200	usd
CY2023Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	1724771	usd
CY2022Q1	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	2302391	usd
CY2023Q1	us-gaap	Gross Profit GrossProfit	1198399	usd
CY2022Q1	us-gaap	Gross Profit GrossProfit	1793517	usd
CY2023Q1	us-gaap	Operating Expenses OperatingExpenses	2908468	usd
CY2022Q1	us-gaap	Operating Expenses OperatingExpenses	2755507	usd
CY2023Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	135895	usd
CY2022Q1	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	3428	usd
CY2023Q1	us-gaap	Net Income Loss NetIncomeLoss	-1574174	usd
CY2022Q1	us-gaap	Net Income Loss NetIncomeLoss	-958562	usd

Files In Submission

Name	View Source	Status
0001628280-23-015243-index-headers.html	Edgar Link	pending
0001628280-23-015243-index.html	Edgar Link	pending
0001628280-23-015243.txt	Edgar Link	pending
0001628280-23-015243-xbrl.zip	Edgar Link	pending
a10q33123exhibit311.htm	Edgar Link	pending
a10q33123exhibit312.htm	Edgar Link	pending
a10q33123exhibit32.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
nuro-20230331.htm	Edgar Link	pending
nuro-20230331.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R9999.htm	Edgar Link	pending
nuro-20230331_def.xml	Edgar Link	unprocessable
nuro-20230331_htm.xml	Edgar Link	completed
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
nuro-20230331_lab.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
nuro-20230331_cal.xml	Edgar Link	unprocessable
nuro-20230331_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$NURO
NeuroMetrix, Inc. Stock $nuro

2023 Q2 Form 10-Q Financial Statement

#000162828023015243 Filed on May 03, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NURO NeuroMetrix, Inc. Stock $nuro

2023 Q2 Form 10-Q Financial Statement

#000162828023015243 Filed on May 03, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$NURO
NeuroMetrix, Inc. Stock $nuro